Q-Line Biotech
Q-Line Biotech Share Price Chart
Q-Line Biotech last traded at ₹606.00 (2026-10-13). Over the past month the stock moved -15.2%. Its closing range over 52 weeks is ₹512.00 – ₹726.20, with the latest close 16.6% below the high.
Closing prices up to 2026-10-13.
About Q-Line Biotech
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing a diverse range of reagents.[1]
Business Profile:[1] Q-Line Biotech is an Indian in-vitro diagnostics (IVD) company engaged in developing, manufacturing, marketing and distributing diagnostic reagents, consumables, point-of-care (POC) devices and diagnostic equipment. The company primarily serves diagnostic laboratories, hospitals and medical colleges through a B2B distribution-led model.
Fundamentals
Annual Financials
In the latest year (Mar 2025), Q-Line Biotech reported sales of ₹314.00 crore (+54.7%) and net profit of ₹28.00 crore (-17.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2025 | 314.00 | 75.00 | 24.00 | 28.00 | 178.60 |
| Mar 2024 | 203.00 | 38.00 | 19.00 | 34.00 | 218.67 |
| Mar 2023 | 183.00 | 34.00 | 18.00 | 32.00 | 203.81 |
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Sales growth | +10.9% | +54.7% |
| Operating profit growth | +11.8% | +97.4% |
| Net profit growth | +6.3% | -17.6% |
| EPS growth | +7.3% | -18.3% |
| OPM % | 19.0% | 24.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Q-Line Biotech.
Get Free AI Stock Analysis FREE →Latest News
-
Q-Line Biotech FY26 PAT rises 190%, EBITDA margin expands to 28.7% - scanx.trade
Frequently Asked Questions
What is the share price of Q-Line Biotech today?
Q-Line Biotech shares were last quoted at ₹606.00 (-4.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Q-Line Biotech?
Q-Line Biotech has a price-to-earnings (P/E) ratio of 27.91 and a price-to-book (P/B) ratio of 6.58. The industry P/E is 45.63.
What is the 52-week high and low of Q-Line Biotech?
The 52-week high of Q-Line Biotech is ₹735.00 and the 52-week low is ₹431.00.
What is the market cap of Q-Line Biotech?
The market capitalisation of Q-Line Biotech is about ₹1,555.29 crore.
What is the promoter holding in Q-Line Biotech?
Promoters hold about 67.51% of Q-Line Biotech.
Which sector does Q-Line Biotech belong to?
Q-Line Biotech belongs to the Medical Equipment/Supplies/Accessories sector.
Other Medical Equipment/Supplies/Accessories stocks
- Poly Medicure
- Indegene
- Molbio Diagnostics
- Aarti Pharmalabs
- Hemant Surgical Industries
- Prevest Denpro
- QMS Medical Allied Services
- Nureca
All Medical Equipment/Supplies/Accessories stocks · Browse all stocks A–Z